These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2478453

  • 1. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
    Asensi V, Kimeno K, Kawamura I, Sakumoto M, Nomoto K.
    Immunology; 1989 Oct; 68(2):204-8. PubMed ID: 2478453
    [Abstract] [Full Text] [Related]

  • 2. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE, Wofsy D, Greenspan JS, Ledbetter JA.
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF, Roths JB, Holmes KL, Rudikoff E, Morse HC.
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [Abstract] [Full Text] [Related]

  • 4. Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity.
    Pisetsky DS, Hoch SO, Klatt CL, O'Donnell MA, Keene JD.
    J Immunol; 1985 Dec; 135(6):4080-5. PubMed ID: 3877763
    [Abstract] [Full Text] [Related]

  • 5. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K, Hamano T, Kakishita E.
    Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
    [Abstract] [Full Text] [Related]

  • 6. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H, Adachi M, Suematsu S, Miwa K, Suda T, Yoshida N, Nagata S.
    J Immunol; 1998 Apr 15; 160(8):3805-11. PubMed ID: 9558084
    [Abstract] [Full Text] [Related]

  • 7. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.
    Mountz JD, Gause WC, Finkelman FD, Steinberg AD.
    J Immunol; 1988 May 01; 140(9):2943-9. PubMed ID: 2834447
    [Abstract] [Full Text] [Related]

  • 8. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL, Himeno K, Tsuru S, Nomoto K.
    Clin Exp Immunol; 1987 Oct 01; 70(1):94-101. PubMed ID: 3500817
    [Abstract] [Full Text] [Related]

  • 9. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 10. A new lymphocyte surface antigen defined by a monoclonal antibody (9F3) to the T cell population expanding in MRL/Mp-lpr/lpr mice.
    Dumont FJ, Habbersett RC, Nichols EA.
    J Immunol; 1984 Aug 01; 133(2):809-15. PubMed ID: 6234361
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T, Davidson WF.
    J Immunol; 1994 Feb 15; 152(4):2000-10. PubMed ID: 8120404
    [Abstract] [Full Text] [Related]

  • 12. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM, Yeh ET, Sy MS.
    J Immunol; 1987 Aug 01; 139(3):734-42. PubMed ID: 3110283
    [Abstract] [Full Text] [Related]

  • 13. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978
    [Abstract] [Full Text] [Related]

  • 14. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice.
    Takei F.
    J Immunol; 1984 Oct 15; 133(4):1951-4. PubMed ID: 6332141
    [Abstract] [Full Text] [Related]

  • 15. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 16. Lack of association of V beta 8+ T cells with lupus-like syndrome in MRL-lpr/lpr mice.
    Fossati L, Merino R, Iwamoto M, Lemoine R, Izui S.
    Eur J Immunol; 1994 Jul 01; 24(7):1717-20. PubMed ID: 8026533
    [Abstract] [Full Text] [Related]

  • 17. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F, Tsukimoto M, Nakatsukasa H, Kojima S.
    Radiat Res; 2008 Jan 01; 169(1):59-66. PubMed ID: 18159952
    [Abstract] [Full Text] [Related]

  • 18. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [Abstract] [Full Text] [Related]

  • 19. Constitutive turnover of inositol-containing phospholipids in B220+ T cells from autoimmune-prone MRL-lpr/lpr mice.
    Tomita-Yamaguchi M, Santoro TJ.
    J Immunol; 1990 May 15; 144(10):3946-52. PubMed ID: 1692067
    [Abstract] [Full Text] [Related]

  • 20. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
    Mountz JD, Smith HR, Wilder RL, Reeves JP, Steinberg AD.
    J Immunol; 1987 Jan 01; 138(1):157-63. PubMed ID: 3537128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.